» Articles » PMID: 35949707

Managements of Osteoporotic Vertebral Compression Fractures: A Narrative Review

Overview
Journal World J Orthop
Specialty Orthopedics
Date 2022 Aug 11
PMID 35949707
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoporotic vertebral compression fractures (OVCFs) are the most common fragility fracture and significantly influence the quality of life in the elderly. Currently, the literature lacks a comprehensive narrative review of the management of OVCFs. The purpose of this study is to review background information, diagnosis, and surgical and non-surgical management of the OVCFs. A comprehensive search of PubMed and Google Scholar for articles in the English language between 1980 and 2021 was performed. Combinations of the following terms were used: compression fractures, vertebral compression fractures, osteoporosis, osteoporotic compression fractures, vertebroplasty, kyphoplasty, bisphosphonates, calcitonin, and osteoporosis treatments. Additional articles were also included by examining the reference list of articles found in the search. OVCFs, especially those that occur over long periods, can be asymptomatic. Symptoms of acute OVCFs include pain localized to the mid-line spine, a loss in height, and decreased mobility. The primary treatment regimens are pain control, medication management, vertebral augmentation, and anterior or posterior decompression and reconstructions. Pain control can be achieved with acetaminophen or nonsteroidal anti-inflammatory drugs for mild pain or opioids and/or calcitonin for moderate to severe pain. Bisphosphonates and denosumab are the first-line treatments for osteoporosis. Vertebroplasty and kyphoplasty are reserved for patients who have not found symptomatic relief through conservative methods and are effective in achieving pain relief. Vertebroplasty is less technical and cheaper than kyphoplasty but could have more complications. Calcium and vitamin D supplementation can have a protective and therapeutic effect. Management of OVCFs must be combined with multiple approaches. Appropriate exercises and activity modification are important in fracture prevention. Medication with different mechanisms of action is a critical long-term causal treatment strategy. The minimally invasive surgical interventions such as vertebroplasty and kyphoplasty are reserved for patients not responsive to conservative therapy and are recognized as efficient stopgap treatment methods. Posterior decompression and fixation or Anterior decompression and reconstruction may be required if neurological deficits are present. The detailed pathogenesis and related targeted treatment options still need to be developed for better clinical outcomes.

Citing Articles

Targeting Caveolin-1 for enhanced rotator cuff repair: findings from single-cell RNA sequencing.

Fang S, Wu S, Chen P Cell Death Discov. 2025; 11(1):88.

PMID: 40044676 PMC: 11882801. DOI: 10.1038/s41420-025-02359-2.


Risk factor analysis of adjacent vertebral compression fracture following the surgery of percutaneous kyphoplasty in postmenopausal women.

Wu F, Chen X, Jiang R, Li L, Qin L, Qi W Sci Rep. 2025; 15(1):5772.

PMID: 39962092 PMC: 11833088. DOI: 10.1038/s41598-025-85381-9.


Cement-Augmented Versus Conventional Pedicle Screws in Surgical Management of Osteoporotic Vertebral Fractures.

Arimura D, Wakiya H, Katsumi S, Obata S, Shinohara A, Saito M Cureus. 2025; 16(12):e76091.

PMID: 39901888 PMC: 11790185. DOI: 10.7759/cureus.76091.


Factors Influencing the Development of Metachronous Fractures in Patients with Osteoporotic Vertebral Fractures Treated with Conservative Management or Vertebroplasty.

Ruiz Santiago F, Bueno Caravaca L, Garrido Sanz F, Jimenez Gutierrez P, Luengo Gomez D, Rivera Izquierdo M Diagnostics (Basel). 2025; 15(2).

PMID: 39857044 PMC: 11765220. DOI: 10.3390/diagnostics15020160.


Risk factors of short-term residual low back pain after PKP for the first thoracolumbar osteoporotic vertebral compression fracture.

Shen L, Yang H, Zhou F, Jiang T, Jiang Z J Orthop Surg Res. 2024; 19(1):792.

PMID: 39587591 PMC: 11590304. DOI: 10.1186/s13018-024-05295-6.


References
1.
Harris S, Watts N, Genant H, McKeever C, Hangartner T, Keller M . Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999; 282(14):1344-52. DOI: 10.1001/jama.282.14.1344. View

2.
Deramond H, Depriester C, GALIBERT P, Le Gars D . Percutaneous vertebroplasty with polymethylmethacrylate. Technique, indications, and results. Radiol Clin North Am. 1998; 36(3):533-46. DOI: 10.1016/s0033-8389(05)70042-7. View

3.
Busse J, Wang L, Kamaleldin M, Craigie S, Riva J, Montoya L . Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysis. JAMA. 2018; 320(23):2448-2460. PMC: 6583638. DOI: 10.1001/jama.2018.18472. View

4.
Prost S, Pesenti S, Fuentes S, Tropiano P, Blondel B . Treatment of osteoporotic vertebral fractures. Orthop Traumatol Surg Res. 2020; 107(1S):102779. DOI: 10.1016/j.otsr.2020.102779. View

5.
Buchbinder R, Osborne R, Ebeling P, Wark J, Mitchell P, Wriedt C . A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med. 2009; 361(6):557-68. DOI: 10.1056/NEJMoa0900429. View